Quarterly report pursuant to Section 13 or 15(d)

Stock-Based Compensation (Details 1)

v3.21.2
Stock-Based Compensation (Details 1) - USD ($)
3 Months Ended 6 Months Ended
Mar. 31, 2021
Jun. 30, 2021
Stockholders' and Members' Deficit    
Number of Shares, Granted 398,199  
Number of Shares, Outstanding, Ending Balance 398,199 398,199
Number of shares, vested and exercisable   209,915
Weighted Average Exercise Price, Outstanding, Beginning Balance $ 0.00 $ 0.00
Weighted Average Exercise Price, Granted 5.83 0.00
Weighted Average Exercise Price, Cancelled/Forfeited 0.00 0.00
Weighted Average Exercise Price, Expired 0.00 0.00
Weighted Average Exercise Price, Outstanding, Ending Balance $ 5.83 5.83
Weighted average exercise price, vested and exercisable   $ 5.76
Weighted average remaining contract term, Granted 9 years 3 months 18 days  
Weighted average remaining contract term, Ending 9 years 3 months 18 days 9 years
Weighted average remaining contract term, Vested and exercisable   9 years 7 months 6 days
Weighted average intrinsic value, Granted $ 0  
Weighted average intrinsic value, Cancelled/Forfeited 0 $ 0
Weighted average intrinsic value, Expired $ 0 $ 0